HEADER TRANSFERASE 27-AUG-01 1JUT
TITLE E. COLI THYMIDYLATE SYNTHASE BOUND TO DUMP AND LY338529, A PYRROLO(2,
TITLE 2 3-D)PYRIMIDINE-BASED ANTIFOLATE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: THYMIDYLATE SYNTHASE;
COMPND 3 CHAIN: A, B;
COMPND 4 SYNONYM: TS;
COMPND 5 EC: 2.1.1.45;
COMPND 6 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI;
SOURCE 3 ORGANISM_TAXID: 562;
SOURCE 4 GENE: THYA;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 7 EXPRESSION_SYSTEM_STRAIN: X2913;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PTHYA-WT
KEYWDS ANTIFOLATE, DTMP SYNTHESIS, CANCER, DRUG RESISTANCE, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR P.H.SAYRE,J.S.FINER-MOORE,T.A.FRITZ,D.BIERMANN,S.B.GATES,
AUTHOR 2 W.C.MACKELLAR,V.F.PATEL,R.M.STROUD
REVDAT 6 06-NOV-24 1JUT 1 REMARK
REVDAT 5 16-AUG-23 1JUT 1 REMARK SEQADV LINK
REVDAT 4 13-JUL-11 1JUT 1 VERSN
REVDAT 3 24-FEB-09 1JUT 1 VERSN
REVDAT 2 12-APR-05 1JUT 1 JRNL
REVDAT 1 19-SEP-01 1JUT 0
JRNL AUTH P.H.SAYRE,J.S.FINER-MOORE,T.A.FRITZ,D.BIERMANN,S.B.GATES,
JRNL AUTH 2 W.C.MACKELLAR,V.F.PATEL,R.M.STROUD
JRNL TITL MULTI-TARGETED ANTIFOLATES AIMED AT AVOIDING DRUG RESISTANCE
JRNL TITL 2 FORM COVALENT CLOSED INHIBITORY COMPLEXES WITH HUMAN AND
JRNL TITL 3 ESCHERICHIA COLI THYMIDYLATE SYNTHASES.
JRNL REF J.MOL.BIOL. V. 313 813 2001
JRNL REFN ISSN 0022-2836
JRNL PMID 11697906
JRNL DOI 10.1006/JMBI.2001.5074
REMARK 2
REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 REFINEMENT TARGET : ENGH AND HUBER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.59
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1797097.090
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5
REMARK 3 NUMBER OF REFLECTIONS : 16719
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.218
REMARK 3 FREE R VALUE : 0.250
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.900
REMARK 3 FREE R VALUE TEST SET COUNT : 1155
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.40
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2571
REMARK 3 BIN R VALUE (WORKING SET) : 0.2970
REMARK 3 BIN FREE R VALUE : 0.3590
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 6.60
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 183
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.027
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4306
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 98
REMARK 3 SOLVENT ATOMS : 82
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 44.90
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.80
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -0.67000
REMARK 3 B22 (A**2) : -0.67000
REMARK 3 B33 (A**2) : 1.34000
REMARK 3 B12 (A**2) : -1.40000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.32
REMARK 3 ESD FROM SIGMAA (A) : 0.40
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.50
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.009
REMARK 3 BOND ANGLES (DEGREES) : 1.800
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.20
REMARK 3 IMPROPER ANGLES (DEGREES) : 1.170
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.37
REMARK 3 BSOL : 28.64
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : DUMP_LY338529.PARAM
REMARK 3 PARAMETER FILE 4 : FORM.PARAM
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : WATER.TOP
REMARK 3 TOPOLOGY FILE 3 : DUMP_LY338529.TOPO
REMARK 3 TOPOLOGY FILE 4 : FORM.TOPO
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1JUT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-SEP-01.
REMARK 100 THE DEPOSITION ID IS D_1000014207.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 28-APR-98
REMARK 200 TEMPERATURE (KELVIN) : 296
REMARK 200 PH : 8
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178
REMARK 200 MONOCHROMATOR : GRAPHITE
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16866
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700
REMARK 200 RESOLUTION RANGE LOW (A) : 30.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : 5.800
REMARK 200 R MERGE (I) : 0.16300
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.0
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.60000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.900
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: CNS
REMARK 200 STARTING MODEL: PDB ENTRY 2KCE
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 50.92
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.51
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: KPO4, MGCL2, DTT, EDTA, AMMONIUM
REMARK 280 SULPHATE, PH 8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 296K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z
REMARK 290 3555 -X+Y,-X,Z
REMARK 290 4555 -X,-Y,Z+1/2
REMARK 290 5555 Y,-X+Y,Z+1/2
REMARK 290 6555 X-Y,X,Z+1/2
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 33.53150
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 33.53150
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 33.53150
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 7580 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 19540 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 OD2 ASP A 139 OE1 GLU A 248 6554 1.91
REMARK 500 OD2 ASP A 139 NZ LYS A 233 6554 2.06
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: COVALENT BOND ANGLES
REMARK 500
REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES
REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE
REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1)
REMARK 500
REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999
REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996
REMARK 500
REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3
REMARK 500 LEU A 27 N - CA - C ANGL. DEV. = -16.2 DEGREES
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 PRO A 43 60.67 -68.99
REMARK 500 TYR A 94 -64.16 -22.18
REMARK 500 ALA A 100 69.61 -151.54
REMARK 500 ASP A 122 54.42 -159.52
REMARK 500 LYS B 48 124.94 -170.31
REMARK 500 TYR B 94 -74.20 -15.20
REMARK 500 ALA B 100 65.47 -150.71
REMARK 500 ASP B 122 56.99 -149.66
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP A 302
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LYD A 303
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE UMP B 304
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LYD B 305
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1JTQ RELATED DB: PDB
REMARK 900 E. COLI TS BOUND TO DUMP AND LY341770
REMARK 900 RELATED ID: 1JTU RELATED DB: PDB
REMARK 900 E. COLI TS BOUND TO DUMP AND POLYGLUTAMYLATED LY231514
REMARK 900 RELATED ID: 1JU6 RELATED DB: PDB
REMARK 900 HUMAN TS BOUND TO DUMP AND LY231514
REMARK 900 RELATED ID: 1JUJ RELATED DB: PDB
REMARK 900 HUMAN THYMIDYLATE SYNTHASE BOUND TO DUMP AND LY231514, A PYRROLO(2,
REMARK 900 3-D)PYRIMIDINE-BASED ANTIFOLATE
DBREF 1JUT A 1 264 UNP P0A884 TYSY_ECOLI 1 264
DBREF 1JUT B 1 264 UNP P0A884 TYSY_ECOLI 1 264
SEQADV 1JUT CXM A 1 UNP P0A884 MET 1 MODIFIED RESIDUE
SEQADV 1JUT CXM B 1 UNP P0A884 MET 1 MODIFIED RESIDUE
SEQRES 1 A 264 CXM LYS GLN TYR LEU GLU LEU MET GLN LYS VAL LEU ASP
SEQRES 2 A 264 GLU GLY THR GLN LYS ASN ASP ARG THR GLY THR GLY THR
SEQRES 3 A 264 LEU SER ILE PHE GLY HIS GLN MET ARG PHE ASN LEU GLN
SEQRES 4 A 264 ASP GLY PHE PRO LEU VAL THR THR LYS ARG CYS HIS LEU
SEQRES 5 A 264 ARG SER ILE ILE HIS GLU LEU LEU TRP PHE LEU GLN GLY
SEQRES 6 A 264 ASP THR ASN ILE ALA TYR LEU HIS GLU ASN ASN VAL THR
SEQRES 7 A 264 ILE TRP ASP GLU TRP ALA ASP GLU ASN GLY ASP LEU GLY
SEQRES 8 A 264 PRO VAL TYR GLY LYS GLN TRP ARG ALA TRP PRO THR PRO
SEQRES 9 A 264 ASP GLY ARG HIS ILE ASP GLN ILE THR THR VAL LEU ASN
SEQRES 10 A 264 GLN LEU LYS ASN ASP PRO ASP SER ARG ARG ILE ILE VAL
SEQRES 11 A 264 SER ALA TRP ASN VAL GLY GLU LEU ASP LYS MET ALA LEU
SEQRES 12 A 264 ALA PRO CYS HIS ALA PHE PHE GLN PHE TYR VAL ALA ASP
SEQRES 13 A 264 GLY LYS LEU SER CYS GLN LEU TYR GLN ARG SER CYS ASP
SEQRES 14 A 264 VAL PHE LEU GLY LEU PRO PHE ASN ILE ALA SER TYR ALA
SEQRES 15 A 264 LEU LEU VAL HIS MET MET ALA GLN GLN CYS ASP LEU GLU
SEQRES 16 A 264 VAL GLY ASP PHE VAL TRP THR GLY GLY ASP THR HIS LEU
SEQRES 17 A 264 TYR SER ASN HIS MET ASP GLN THR HIS LEU GLN LEU SER
SEQRES 18 A 264 ARG GLU PRO ARG PRO LEU PRO LYS LEU ILE ILE LYS ARG
SEQRES 19 A 264 LYS PRO GLU SER ILE PHE ASP TYR ARG PHE GLU ASP PHE
SEQRES 20 A 264 GLU ILE GLU GLY TYR ASP PRO HIS PRO GLY ILE LYS ALA
SEQRES 21 A 264 PRO VAL ALA ILE
SEQRES 1 B 264 CXM LYS GLN TYR LEU GLU LEU MET GLN LYS VAL LEU ASP
SEQRES 2 B 264 GLU GLY THR GLN LYS ASN ASP ARG THR GLY THR GLY THR
SEQRES 3 B 264 LEU SER ILE PHE GLY HIS GLN MET ARG PHE ASN LEU GLN
SEQRES 4 B 264 ASP GLY PHE PRO LEU VAL THR THR LYS ARG CYS HIS LEU
SEQRES 5 B 264 ARG SER ILE ILE HIS GLU LEU LEU TRP PHE LEU GLN GLY
SEQRES 6 B 264 ASP THR ASN ILE ALA TYR LEU HIS GLU ASN ASN VAL THR
SEQRES 7 B 264 ILE TRP ASP GLU TRP ALA ASP GLU ASN GLY ASP LEU GLY
SEQRES 8 B 264 PRO VAL TYR GLY LYS GLN TRP ARG ALA TRP PRO THR PRO
SEQRES 9 B 264 ASP GLY ARG HIS ILE ASP GLN ILE THR THR VAL LEU ASN
SEQRES 10 B 264 GLN LEU LYS ASN ASP PRO ASP SER ARG ARG ILE ILE VAL
SEQRES 11 B 264 SER ALA TRP ASN VAL GLY GLU LEU ASP LYS MET ALA LEU
SEQRES 12 B 264 ALA PRO CYS HIS ALA PHE PHE GLN PHE TYR VAL ALA ASP
SEQRES 13 B 264 GLY LYS LEU SER CYS GLN LEU TYR GLN ARG SER CYS ASP
SEQRES 14 B 264 VAL PHE LEU GLY LEU PRO PHE ASN ILE ALA SER TYR ALA
SEQRES 15 B 264 LEU LEU VAL HIS MET MET ALA GLN GLN CYS ASP LEU GLU
SEQRES 16 B 264 VAL GLY ASP PHE VAL TRP THR GLY GLY ASP THR HIS LEU
SEQRES 17 B 264 TYR SER ASN HIS MET ASP GLN THR HIS LEU GLN LEU SER
SEQRES 18 B 264 ARG GLU PRO ARG PRO LEU PRO LYS LEU ILE ILE LYS ARG
SEQRES 19 B 264 LYS PRO GLU SER ILE PHE ASP TYR ARG PHE GLU ASP PHE
SEQRES 20 B 264 GLU ILE GLU GLY TYR ASP PRO HIS PRO GLY ILE LYS ALA
SEQRES 21 B 264 PRO VAL ALA ILE
MODRES 1JUT CXM A 1 MET N-CARBOXYMETHIONINE
MODRES 1JUT CXM B 1 MET N-CARBOXYMETHIONINE
HET CXM A 1 11
HET CXM B 1 11
HET UMP A 302 20
HET LYD A 303 29
HET UMP B 304 20
HET LYD B 305 29
HETNAM CXM N-CARBOXYMETHIONINE
HETNAM UMP 2'-DEOXYURIDINE 5'-MONOPHOSPHATE
HETNAM LYD 2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-
HETNAM 2 LYD D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-
HETNAM 3 LYD BUTYRIC ACID
HETSYN UMP DUMP
HETSYN LYD LY338529
FORMUL 1 CXM 2(C6 H11 N O4 S)
FORMUL 3 UMP 2(C9 H13 N2 O8 P)
FORMUL 4 LYD 2(C20 H23 N5 O4)
FORMUL 7 HOH *82(H2 O)
HELIX 1 1 CXM A 1 GLY A 15 1 15
HELIX 2 2 GLN A 39 GLY A 41 5 3
HELIX 3 3 HIS A 51 GLN A 64 1 14
HELIX 4 4 ILE A 69 ASN A 75 1 7
HELIX 5 5 TRP A 80 ALA A 84 5 5
HELIX 6 6 VAL A 93 ALA A 100 1 8
HELIX 7 7 ASP A 110 ASP A 122 1 13
HELIX 8 8 GLU A 137 MET A 141 5 5
HELIX 9 9 LEU A 172 CYS A 192 1 21
HELIX 10 10 HIS A 212 SER A 221 1 10
HELIX 11 11 SER A 238 TYR A 242 5 5
HELIX 12 12 ARG A 243 GLU A 245 5 3
HELIX 13 13 CXM B 1 GLY B 15 1 15
HELIX 14 14 GLN B 39 GLY B 41 5 3
HELIX 15 15 HIS B 51 GLN B 64 1 14
HELIX 16 16 ILE B 69 ASN B 75 1 7
HELIX 17 17 TRP B 80 ALA B 84 5 5
HELIX 18 18 VAL B 93 ALA B 100 1 8
HELIX 19 19 ASP B 110 ASP B 122 1 13
HELIX 20 20 ASN B 134 MET B 141 5 8
HELIX 21 21 LEU B 172 CYS B 192 1 21
HELIX 22 22 HIS B 212 SER B 221 1 10
HELIX 23 23 ARG B 243 GLU B 245 5 3
SHEET 1 A 6 THR A 16 LYS A 18 0
SHEET 2 A 6 THR A 26 ASN A 37 -1 O THR A 26 N LYS A 18
SHEET 3 A 6 GLU A 195 TYR A 209 -1 O THR A 206 N ILE A 29
SHEET 4 A 6 LYS A 158 ASP A 169 1 N LEU A 159 O GLU A 195
SHEET 5 A 6 HIS A 147 ALA A 155 -1 N TYR A 153 O SER A 160
SHEET 6 A 6 ILE A 129 SER A 131 -1 N VAL A 130 O PHE A 150
SHEET 1 B 2 TRP A 101 PRO A 102 0
SHEET 2 B 2 HIS A 108 ILE A 109 -1 O ILE A 109 N TRP A 101
SHEET 1 C 2 LYS A 229 ILE A 232 0
SHEET 2 C 2 PHE A 247 GLU A 250 -1 O GLU A 250 N LYS A 229
SHEET 1 D 6 THR B 16 LYS B 18 0
SHEET 2 D 6 THR B 26 ASN B 37 -1 O SER B 28 N THR B 16
SHEET 3 D 6 GLU B 195 TYR B 209 -1 O PHE B 199 N PHE B 36
SHEET 4 D 6 LYS B 158 ASP B 169 1 N GLN B 165 O THR B 202
SHEET 5 D 6 HIS B 147 ALA B 155 -1 N TYR B 153 O SER B 160
SHEET 6 D 6 ILE B 129 SER B 131 -1 N VAL B 130 O PHE B 150
SHEET 1 E 2 TRP B 101 PRO B 102 0
SHEET 2 E 2 HIS B 108 ILE B 109 -1 O ILE B 109 N TRP B 101
SHEET 1 F 2 LYS B 229 ILE B 232 0
SHEET 2 F 2 PHE B 247 GLU B 250 -1 O GLU B 248 N ILE B 231
LINK C CXM A 1 N LYS A 2 1555 1555 1.32
LINK SG CYS A 146 C6 UMP A 302 1555 1555 1.60
LINK C CXM B 1 N LYS B 2 1555 1555 1.33
SITE 1 AC1 15 ARG A 21 CYS A 146 HIS A 147 GLN A 165
SITE 2 AC1 15 ARG A 166 SER A 167 CYS A 168 ASP A 169
SITE 3 AC1 15 ASN A 177 HIS A 207 TYR A 209 LYD A 303
SITE 4 AC1 15 HOH A 451 ARG B 126 ARG B 127
SITE 1 AC2 13 ILE A 79 TRP A 80 TRP A 83 LEU A 143
SITE 2 AC2 13 ASP A 169 LEU A 172 GLY A 173 PHE A 176
SITE 3 AC2 13 ALA A 263 UMP A 302 HOH A 413 HOH A 473
SITE 4 AC2 13 HOH A 474
SITE 1 AC3 15 ARG A 126 ARG A 127 ARG B 21 CYS B 146
SITE 2 AC3 15 HIS B 147 GLN B 165 ARG B 166 SER B 167
SITE 3 AC3 15 CYS B 168 ASP B 169 ASN B 177 HIS B 207
SITE 4 AC3 15 TYR B 209 LYD B 305 HOH B 462
SITE 1 AC4 10 TRP B 80 TRP B 83 ASP B 169 GLY B 173
SITE 2 AC4 10 PHE B 176 VAL B 262 ALA B 263 UMP B 304
SITE 3 AC4 10 HOH B 414 HOH B 472
CRYST1 125.800 125.800 67.063 90.00 90.00 120.00 P 63 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007949 0.004589 0.000000 0.00000
SCALE2 0.000000 0.009179 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014911 0.00000
HETATM 1 N CXM A 1 21.831 20.124 49.357 1.00 21.31 N
HETATM 2 CA CXM A 1 23.156 20.634 49.779 1.00 21.07 C
HETATM 3 CB CXM A 1 24.265 19.997 48.928 1.00 21.56 C
HETATM 4 CG CXM A 1 23.954 19.894 47.439 1.00 24.16 C
HETATM 5 SD CXM A 1 24.977 18.701 46.516 1.00 24.83 S
HETATM 6 CE CXM A 1 26.531 18.913 47.341 1.00 25.76 C
HETATM 7 C CXM A 1 23.215 22.148 49.708 1.00 20.87 C
HETATM 8 O CXM A 1 22.627 22.774 48.844 1.00 19.05 O
HETATM 9 CN CXM A 1 21.417 18.877 49.723 1.00 21.88 C
HETATM 10 ON1 CXM A 1 22.245 18.041 50.163 1.00 25.10 O
HETATM 11 ON2 CXM A 1 20.204 18.592 49.615 1.00 21.17 O